S&P 500   4,049.05 (+0.53%)
DOW   32,856.25 (+0.42%)
QQQ   315.52 (+0.90%)
AAPL   162.04 (+0.79%)
MSFT   283.80 (+1.17%)
META   207.61 (+1.10%)
GOOGL   100.91 (-0.47%)
AMZN   101.94 (+1.69%)
TSLA   195.71 (+0.94%)
NVDA   273.92 (+1.51%)
NIO   10.43 (+6.10%)
BABA   103.60 (+3.68%)
AMD   97.92 (+1.90%)
T   19.11 (+0.58%)
F   12.25 (+1.66%)
MU   62.80 (-1.16%)
CGC   1.77 (-2.21%)
GE   94.03 (-0.03%)
DIS   98.03 (+1.20%)
AMC   4.90 (-2.00%)
PFE   40.32 (+0.17%)
PYPL   74.34 (+0.22%)
NFLX   339.42 (+2.23%)
S&P 500   4,049.05 (+0.53%)
DOW   32,856.25 (+0.42%)
QQQ   315.52 (+0.90%)
AAPL   162.04 (+0.79%)
MSFT   283.80 (+1.17%)
META   207.61 (+1.10%)
GOOGL   100.91 (-0.47%)
AMZN   101.94 (+1.69%)
TSLA   195.71 (+0.94%)
NVDA   273.92 (+1.51%)
NIO   10.43 (+6.10%)
BABA   103.60 (+3.68%)
AMD   97.92 (+1.90%)
T   19.11 (+0.58%)
F   12.25 (+1.66%)
MU   62.80 (-1.16%)
CGC   1.77 (-2.21%)
GE   94.03 (-0.03%)
DIS   98.03 (+1.20%)
AMC   4.90 (-2.00%)
PFE   40.32 (+0.17%)
PYPL   74.34 (+0.22%)
NFLX   339.42 (+2.23%)
S&P 500   4,049.05 (+0.53%)
DOW   32,856.25 (+0.42%)
QQQ   315.52 (+0.90%)
AAPL   162.04 (+0.79%)
MSFT   283.80 (+1.17%)
META   207.61 (+1.10%)
GOOGL   100.91 (-0.47%)
AMZN   101.94 (+1.69%)
TSLA   195.71 (+0.94%)
NVDA   273.92 (+1.51%)
NIO   10.43 (+6.10%)
BABA   103.60 (+3.68%)
AMD   97.92 (+1.90%)
T   19.11 (+0.58%)
F   12.25 (+1.66%)
MU   62.80 (-1.16%)
CGC   1.77 (-2.21%)
GE   94.03 (-0.03%)
DIS   98.03 (+1.20%)
AMC   4.90 (-2.00%)
PFE   40.32 (+0.17%)
PYPL   74.34 (+0.22%)
NFLX   339.42 (+2.23%)
S&P 500   4,049.05 (+0.53%)
DOW   32,856.25 (+0.42%)
QQQ   315.52 (+0.90%)
AAPL   162.04 (+0.79%)
MSFT   283.80 (+1.17%)
META   207.61 (+1.10%)
GOOGL   100.91 (-0.47%)
AMZN   101.94 (+1.69%)
TSLA   195.71 (+0.94%)
NVDA   273.92 (+1.51%)
NIO   10.43 (+6.10%)
BABA   103.60 (+3.68%)
AMD   97.92 (+1.90%)
T   19.11 (+0.58%)
F   12.25 (+1.66%)
MU   62.80 (-1.16%)
CGC   1.77 (-2.21%)
GE   94.03 (-0.03%)
DIS   98.03 (+1.20%)
AMC   4.90 (-2.00%)
PFE   40.32 (+0.17%)
PYPL   74.34 (+0.22%)
NFLX   339.42 (+2.23%)
NASDAQ:ALEC

Alector - ALEC Stock Forecast, Price & News

$6.09
-0.22 (-3.49%)
(As of 03/30/2023 03:45 PM ET)
Add
Compare
Today's Range
$6.05
$6.42
50-Day Range
$5.85
$9.84
52-Week Range
$5.76
$15.39
Volume
215,310 shs
Average Volume
565,706 shs
Market Capitalization
$505.65 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$15.38

Alector MarketRank™ Forecast

Analyst Rating
Hold
2.43 Rating Score
Upside/​Downside
152.0% Upside
$15.38 Price Target
Short Interest
Bearish
9.06% of Float Sold Short
Dividend Strength
N/A
Sustainability
-0.92
Upright™ Environmental Score
News Sentiment
0.68mentions of Alector in the last 14 days
Based on 2 Articles This Week
Insider Trading
Selling Shares
$180,802 Sold Last Quarter
Proj. Earnings Growth
Growing
From ($3.14) to ($2.94) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.59 out of 5 stars

Medical Sector

120th out of 999 stocks

Biological Products, Except Diagnostic Industry

19th out of 166 stocks


ALEC stock logo

About Alector (NASDAQ:ALEC) Stock

Alector, Inc. operates as a clinical-stage biopharmaceutical company, which engages in pioneering of immuno-neurology. It develops portfolio of innate immune system programs, designed to functionally repair genetic mutations and enable the rejuvenated immune cells to counteract emerging brain pathologies. Its treatment targets immune dysfunction as a root cause of multiple pathologies that are drivers of degenerative brain disorders. The company was founded by Asa Abeliovich, Errik B. Anderson, Tillman U. Gerngross, and Arnon Rosenthal in May 2013 and is headquartered in South San Francisco, CA.

Receive ALEC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Alector and its competitors with MarketBeat's FREE daily newsletter.

ALEC Stock News Headlines

Alector (NASDAQ:ALEC) Shares Down 4.7% After Insider Selling
The gold catalyst we’ve waited for
If you thought the SVB meltdown was bad… watch out. Because even bigger red flag just appeared. This signal proves that a recession is likely right around the corner. It will take most by surprise. Stocks will crash. Millions will go jobless, and lose their homes. But there is ONE important step you should take today to make sure you come out the other side OK.
Adam Mesh: “This Strategy Saved My Trading Career”
Adam Mesh was $50,000 in the hole - and ready to quit trading for good… Until he discovered the secret to unlocking double-digit income. This strategy has averaged 64% average gains in the last three years. Adam is hosting a free session to show ordinary folks how to execute this incredible strategy. Click here to let Adam show you how it’s done. pixel
Alector Third Quarter 2022 Earnings: Misses Expectations
See More Headlines
Receive ALEC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Alector and its competitors with MarketBeat's FREE daily newsletter.

ALEC Company Calendar

Last Earnings
2/28/2023
Today
3/30/2023
Next Earnings (Estimated)
5/04/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Biological products, except diagnostic
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:ALEC
Fax
N/A
Employees
208
Year Founded
2013

Price Target and Rating

Average Stock Price Forecast
$15.38
High Stock Price Forecast
$41.00
Low Stock Price Forecast
$6.00
Forecasted Upside/Downside
+144.8%
Consensus Rating
Hold
Rating Score (0-4)
2.43
Research Coverage
7 Analysts

Profitability

Net Income
$-133,310,000.00
Pretax Margin
-97.33%

Debt

Sales & Book Value

Annual Sales
$133.62 million
Book Value
$2.59 per share

Miscellaneous

Free Float
72,326,000
Market Cap
$521.43 million
Optionable
Not Optionable
Beta
0.83

Social Links


Key Executives

  • Arnon RosenthalArnon Rosenthal
    Chief Executive Officer & Director
  • Saraswati Kenkare-Mitra
    President, Head-Research & Development
  • Marc Edward Grasso
    Chief Financial, Accounting & Business Officer
  • Charles Wolfus
    VP-Technology & Digital Health
  • Gary Romano
    Chief Medical Officer













ALEC Stock - Frequently Asked Questions

Should I buy or sell Alector stock right now?

7 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Alector in the last twelve months. There are currently 1 sell rating, 2 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" ALEC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ALEC, but not buy additional shares or sell existing shares.
View ALEC analyst ratings
or view top-rated stocks.

What is Alector's stock price forecast for 2023?

7 Wall Street analysts have issued 1 year price objectives for Alector's shares. Their ALEC share price forecasts range from $6.00 to $41.00. On average, they expect the company's share price to reach $15.38 in the next year. This suggests a possible upside of 152.0% from the stock's current price.
View analysts price targets for ALEC
or view top-rated stocks among Wall Street analysts.

How have ALEC shares performed in 2023?

Alector's stock was trading at $9.23 at the start of the year. Since then, ALEC shares have decreased by 33.9% and is now trading at $6.10.
View the best growth stocks for 2023 here
.

When is Alector's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 4th 2023.
View our ALEC earnings forecast
.

How were Alector's earnings last quarter?

Alector, Inc. (NASDAQ:ALEC) issued its quarterly earnings data on Tuesday, February, 28th. The company reported ($0.63) EPS for the quarter, missing the consensus estimate of ($0.54) by $0.09. The firm had revenue of $14.44 million for the quarter, compared to analyst estimates of $35.37 million. Alector had a negative net margin of 99.77% and a negative trailing twelve-month return on equity of 52.10%.

What guidance has Alector issued on next quarter's earnings?

Alector updated its FY 2023 earnings guidance on Tuesday, February, 28th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $15.00 million-$25.00 million, compared to the consensus revenue estimate of $25.39 million.

What is Arnon Rosenthal's approval rating as Alector's CEO?

4 employees have rated Alector Chief Executive Officer Arnon Rosenthal on Glassdoor.com. Arnon Rosenthal has an approval rating of 100% among the company's employees. This puts Arnon Rosenthal in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Alector own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Alector investors own include Editas Medicine (EDIT), NVIDIA (NVDA), Pfizer (PFE), Advanced Micro Devices (AMD), Gossamer Bio (GOSS), Kaleido Biosciences (KLDO), QUALCOMM (QCOM), Intel (INTC), Micron Technology (MU) and Cisco Systems (CSCO).

When did Alector IPO?

(ALEC) raised $177 million in an IPO on Thursday, February 7th 2019. The company issued 9,300,000 shares at a price of $18.00-$20.00 per share. Morgan Stanley, BofA Merrill Lynch, Cowen and Barclays served as the underwriters for the IPO.

What is Alector's stock symbol?

Alector trades on the NASDAQ under the ticker symbol "ALEC."

Who are Alector's major shareholders?

Alector's stock is owned by a number of institutional and retail investors. Top institutional investors include JPMorgan Chase & Co. (2.93%), Price T Rowe Associates Inc. MD (2.09%), Franklin Resources Inc. (1.93%), Geode Capital Management LLC (1.44%), Braidwell LP (0.88%) and Morgan Stanley (0.72%). Insiders that own company stock include Arnon Rosenthal, Calvin Yu, Gary Romano, Marc Grasso, Orbimed Advisors Llc, Richard H Scheller, Robert King, Robert Paul, Shehnaaz Suliman and Terrance Mcguire.
View institutional ownership trends
.

How do I buy shares of Alector?

Shares of ALEC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Alector's stock price today?

One share of ALEC stock can currently be purchased for approximately $6.10.

How much money does Alector make?

Alector (NASDAQ:ALEC) has a market capitalization of $506.48 million and generates $133.62 million in revenue each year. The company earns $-133,310,000.00 in net income (profit) each year or ($1.61) on an earnings per share basis.

How many employees does Alector have?

The company employs 208 workers across the globe.

Does Alector have any subsidiaries?
The following companies are subsidiares of Alector: Alector LLC.
Read More
How can I contact Alector?

Alector's mailing address is 131 OYSTER POINT BLVD. SUITE 600, SOUTH SAN FRANCISCO CA, 94080. The official website for the company is www.alector.com. The company can be reached via phone at (415) 231-5660 or via email at ir@alector.com.

This page (NASDAQ:ALEC) was last updated on 3/30/2023 by MarketBeat.com Staff